SYMBIOSIS Pharmaceutical Services has appointed Dr. Thomas Scullion as a U.S. business development manager to aid the company’s growing commercial interests and client relationships in North America for sterile manufacturing.    Dr. Scullion previously worked in business development for the a large drug discovery CRO. He has spent the majority of his career working within the life science industry across both the public and private sectors.   Colin MacKay, chief executive officer at Symbiosi...